Concepedia

Bruno Figueroa

BF

11

Publications

563

Citations

11

H-Index

2001

Active since

Affiliations

Pfizer (United States)(Current)

Johns Hopkins University

Biogen (United States)

University of Maryland, Baltimore

Massachusetts Institute of Technology

Bruno Figueroa is an author at Pfizer (United States) specializing in medicine, cell biology, and cell engineering.

Top concepts

Publications per year

2001–2019

11

Publications

11

Enhanced cell culture performance using inducible anti‐apoptotic genes <i>E1B‐19K</i> and <i>Aven</i> in the production of a monoclonal antibody with Chinese hamster ovary cells

Bruno Figueroa, Eric Ailor, Douglas G. Osborne et al. · Biotechnology and Bioengineering · 2006 · 102 citations

, , +13

Aven and Bcl‐x<sub>L</sub> enhance protection against apoptosis for mammalian cells exposed to various culture conditions

Bruno Figueroa, Sulin Chen, George A. Oyler et al. · Biotechnology and Bioengineering · 2004 · 89 citations

Small-molecule control of antibody N-glycosylation in engineered mammalian cells

Michelle Chang, Leonid Gaidukov, Giyoung Jung et al. · Nature Chemical Biology · 2019 · 70 citations

, , +8

Dissecting N-Glycosylation Dynamics in Chinese Hamster Ovary Cells Fed-batch Cultures using Time Course Omics Analyses

Madhuresh Sumit, Sepideh Dolatshahi, An‐Hsiang Adam Chu et al. · iScience · 2019 · 61 citations · Full text

Comparison of Bcl‐2 to a Bcl‐2 deletion mutant for mammalian cells exposed to culture insults

Bruno Figueroa, Tina M. Sauerwald, Alison J. Mastrangelo et al. · Biotechnology and Bioengineering · 2001 · 53 citations

Rows per page

1–5 of 11